Table 4 Power calculations for secondary outcomes
Outcome | Power | Detectable difference with 20 sites (n = 800) | Detectable difference with 26 sites (n = 1040) |
|---|---|---|---|
Hemolytic uremic syndrome—17.5% in conservative fluid management arm | 80% | 7.2% | 6.3% |
90% | 8.1% | 7.1% | |
Extrarenal complications—7.5% in conservative fluid management arm | 80% | 4.7% | 4.1% |
90% | 5.2% | 4.6% |